Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
G Ital Med Lav Ergon ; 35(1): 32-5, 2013.
Artículo en Italiano | MEDLINE | ID: mdl-23798232

RESUMEN

In several recent epidemiological studies blood lead levels (BLLs) even below the current CDC intervention level of 10 microg/dl have been associated with reduced neurocognitive capacities of children, with no clear evidence of a "safe" threshold. We analyzed the relationship between the BLLs and the neurocognitive capacities of 205 Sardinian students aged 11 to 15 years, using 2 tests of the Swedish Performance Evaluating System (SPES) and the full-scale Intelligence Quotient (IQ) derived from the Wechsler Intelligence Scale for Children (WISC). The studied population included 104 children (61 males and 43 females) living in Portoscuso, a town 2 Km far from a lead smelter (mean BLLs: 5.98 +/- 2.2; max 11.5 microg/dl), and 101 age-matched students (55 males and 46 females) living in Sant'Antioco, a town about 20 Km far from the same smelter (mean BLLs: 2.08 +/- 0.8; max 4.5 microg/dl). Subjects with BLLs above 4 microg/dl performed worse in the SPES tests and scored about 5.0 points less on the full-scale IQ compared to the students with lower BLLs. The adjusted regression coefficients derived from the multivariate analysis showed that higher BLLs were significantly associated with worse performances in the SPES tests and with reduced IQ (0.94 points for each microg/dl of BLL). This study confirms the potential neurotoxicity of low-levels of lead suggesting the need of lowering the actual CDC "limit of concern" for children to values lower than 4 microg/dl, improving at the same time the environmental primary prevention for limiting the lead exposure of subjects living near the lead smelter.


Asunto(s)
Exposición a Riesgos Ambientales/efectos adversos , Monitoreo del Ambiente/métodos , Pruebas de Inteligencia/estadística & datos numéricos , Intoxicación por Plomo/epidemiología , Plomo/sangre , Metalurgia , Estudiantes/estadística & datos numéricos , Adolescente , Niño , Femenino , Humanos , Italia/epidemiología , Intoxicación por Plomo/sangre , Intoxicación por Plomo/diagnóstico , Masculino , Prevalencia , Valores de Referencia , Factores de Riesgo
2.
Curr HIV Res ; 7(4): 378-83, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19601772

RESUMEN

OBJECTIVE: To characterize the functional properties of natural autoantibodies capable of preventing in vitro infection by HIV-1, present in normal human serum (NHS), and denoted as IgG-reactive antibodies. METHODS: IgG-reactive antibodies were affinity purified both from normal human serum (NHS) and from a GammaBind G Sepharose Flowthrough (GBF) fraction of NHS by affinity chromatography on IgG coupled to CNBr-activated Sepharose (IgG-Sepharose). RESULTS: The GBF fraction was shown, by Capture ELISA relative to isotype-matched standards, to contain in addition to IgM and IgA isotypes, a low but constant level of IgG isotype. About 15% of the GBF fraction's IgG, compared to only about 0.3% of the NHS IgG, was affinity purified on IgG-Sepharose. On IgG subclass analysis, in contrast to the characteristic dominance of IgG1 in pooled NHS, the IgG-reactive antibodies obtained from NHS and from the GBF fraction each showed a dominance of IgG2. Western blot analysis confirmed the abundance of IgG2, a major IgG subclass reactive against carbohydrate antigens, and showed the presence of IgG2 dimers. The IgG-reactive antibodies separated from the GBF fraction were able to neutralize HIV-1(BaL) strain with approaching 100% and 80% effectiveness at 2 microg/ml and 0.6 microg/ml, respectively, as well as the primary isolates HIV-1(NDK) (X4-tropic isolate) and HIV-1(JR-CSF) (R5-tropic isolate) with an IC50 between 0.4 microg/ml and 1.8 microg/ml for two different preparations. CONCLUSION: These findings further support our previous proposal for IgG-reactive antibody preparations to be used in the treatment of HIV-1 infected individuals.


Asunto(s)
Fármacos Anti-VIH/farmacología , Anticuerpos Antiidiotipos/farmacología , Infecciones por VIH/virología , VIH-1/efectos de los fármacos , Inmunoglobulina G/farmacología , Fármacos Anti-VIH/inmunología , Fármacos Anti-VIH/aislamiento & purificación , Anticuerpos Antiidiotipos/inmunología , Anticuerpos Antiidiotipos/aislamiento & purificación , Cromatografía de Afinidad , VIH-1/inmunología , VIH-1/aislamiento & purificación , Humanos , Inmunoglobulina G/inmunología , Inmunoglobulina G/aislamiento & purificación , Inmunoterapia/métodos , Concentración 50 Inhibidora , Pruebas de Neutralización
3.
Clin Interv Aging ; 3(1): 97-109, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18494169

RESUMEN

The Mediterranean diet is known to be one of the healthiest dietary patterns in the world due to its relation with a low morbidity and mortality for some chronic diseases. The purpose of this study was to review literature regarding the relationship between Mediterranean diet and healthy aging. A MEDLINE search was conducted looking for literature regarding the relationship between Mediterranean diet and cardiovascular disease (or risk factors for cardiovascular disease), cancer, mental health and longevity and quality of life in the elderly population (65 years or older). A selection of 36 articles met the criteria of selection. Twenty of the studies were about Mediterranean diets and cardiovascular disease, 2 about Mediterranean diets and cancer, 3 about Mediterranean diets and mental health and 11 about longevity (overall survival) or mental health. The results showed that Mediterranean diets had benefits on risks factors for cardiovascular disease such as lipoprotein levels, endothelium vasodilatation, insulin resistance, the prevalence of the metabolic syndrome, antioxidant capacity, the incidence of acute myocardial infarction, and cardiovascular mortality. Some positive associations with quality of life and inverse associations with the risk of certain cancers and with overall mortality were also reported.


Asunto(s)
Enfermedades Cardiovasculares/epidemiología , Dieta Mediterránea , Anciano , Envejecimiento/fisiología , Enfermedades Cardiovasculares/prevención & control , Trastornos del Conocimiento/prevención & control , Conductas Relacionadas con la Salud , Humanos , Síndrome Metabólico/prevención & control , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA